How is the Kazia Therapeutics Limited - ADR today?

The Kazia Therapeutics Limited - ADR today is trading in the green, up by 5.04% at 5.63.

How has Kazia Therapeutics Limited - ADR performed historically?

The Kazia Therapeutics Limited - ADR is currently trading up 5.04% on an intraday basis in the past week the index rose 58.15%. The index has been up 47.38% in the past quarter and fell -54.96% in the past year. You can view this in the overview section.

What is Kazia Therapeutics Limited - ADR Annual Net Profit?

Kazia Therapeutics Limited - ADR Annual Net Profit fell 30.85% in the last year to $26.78 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Kazia Therapeutics Limited - ADR Stock Price?

Kazia Therapeutics Limited - ADR Stock Price fell 54.96% and underperformed its sector by 81.11% in the past year.

What is Kazia Therapeutics Limited - ADR Return on Equity(ROE)?

Kazia Therapeutics Limited - ADR Return on Equity(ROE) for the last financial year was -2,634.33%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Kazia Therapeutics Limited - ADR Mutual Fund Holding?

Kazia Therapeutics Limited - ADR Mutual Fund Holding remained the same in the last quarter at 0.03%.

What is Kazia Therapeutics Limited - ADR Institutional Holding?

Kazia Therapeutics Limited - ADR Institutional Holding decreased by 0.47% in the last quarter to 4.27.

Kazia Therapeutics Limited - ADR XNAS: KZIA

Kazia Therapeutics Limited - ADR Live Share Price Today, Share Analysis and Chart

Name: Kazia Therapeutics Limited - ADR: Is Infosys Ltd. worth buying?
Item: Kazia Therapeutics Limited - ADR
Rating: 0.89675
Author: Trendlyne DVM scores

about

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. ...

5.63 0.27 (5.04%)

92.87% Fall from 52W High

34,234 XNAS Volume

XNAS 05 Jun, 2025 1:58 PM (EDT)

Board Meeting

The next board meeting for Kazia Therapeutics Limited - ADR is on 06 Jun 2025 for the purpose of Kazia Therapeutics Ltd Second Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

35.9 / 100

1Yr Price target upside is 170%

1 analysts

Kazia Therapeutics Limited... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kazia Therapeutics Limited - ADR Live Share Price Today, Share Analysis and Chart

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. ...

92.87% Fall from 52W High

Kazia Therapeutics Limited... Live Price Chart

Kazia Therapeutics Limited - ADR FAQ

How is Kazia Therapeutics Limited - ADR today?

Kazia Therapeutics Limited - ADR today is trading in the green, and is up by 5.04% at 5.63.

How has Kazia Therapeutics Limited - ADR performed historically?

Kazia Therapeutics Limited - ADR is currently trading up 5.04% on an intraday basis. In the past week the stock rose 58.15%. stock has been up 47.38% in the past quarter and fell -54.96% in the past year. You can view this in the overview section.